Catalogue of EQ-5D scores for the United Kingdom
- PMID: 21422468
- DOI: 10.1177/0272989X11401031
Catalogue of EQ-5D scores for the United Kingdom
Abstract
Background: The National Institute for Health and Clinical Excellence (NICE) has issued guidance on cost-effectiveness analyses, suggesting that preference-based health-related quality of life (HRQL) weights or utilities be based on UK community preferences, preferably using the EQ-5D; ideally all analyses would use the same system for deriving HRQL weights, to encourage consistency and comparability across analyses. Development of a catalogue of EQ-5D scores for a range of health conditions based on UK preferences would help achieve many of these goals.
Objective: . To provide a UK-based catalogue of EQ-5D index scores.
Method: s were consistent with the previously published catalogue of EQ-5D scores for the US. Community-based UK preferences were applied to EQ-5D descriptive questionnaire responses in the US-based Medical Expenditure Panel Survey (MEPS). Ordinary least squares (OLS), Tobit, and censored least absolute deviations (CLAD) regression methods were used to estimate the 'marginal disutility' of each condition controlling for covariates.
Results: . Pooled MEPS files (2000-2003) resulted in 79,522 individuals with complete EQ-5D scores. Marginal disutilities for 135 chronic ICD-9 and 100 CCC codes are provided. Unadjusted descriptive statistics including mean, median, 25th and 75th percentiles are also reported.
Conclusion: . This research provides community-based EQ-5D index scores for a wide variety of chronic conditions that can be used to estimate QALYs in cost-effectiveness analyses in the UK. Although using EQ-5D questionnaire responses from the US-based MEPS is less than ideal, the estimates approximate HRQL guidelines by NICE and provide an easily accessible"off-the-shelf" resource for cost-effectiveness and public-health applications.
Similar articles
-
Preference-Based EQ-5D index scores for chronic conditions in the United States.Med Decis Making. 2006 Jul-Aug;26(4):410-20. doi: 10.1177/0272989X06290495. Med Decis Making. 2006. PMID: 16855129 Free PMC article.
-
EQ-5D Scores for Diabetes-Related Comorbidities.Value Health. 2016 Dec;19(8):1002-1008. doi: 10.1016/j.jval.2016.05.018. Epub 2016 Jul 15. Value Health. 2016. PMID: 27987626
-
Mapping the EQ-5D index from the SF-12: US general population preferences in a nationally representative sample.Med Decis Making. 2006 Jul-Aug;26(4):401-9. doi: 10.1177/0272989X06290496. Med Decis Making. 2006. PMID: 16855128 Free PMC article.
-
NICE DSU Technical Support Document 11: Alternatives to EQ-5D for Generating Health State Utility Values [Internet].London: National Institute for Health and Care Excellence (NICE); 2011 Mar. London: National Institute for Health and Care Excellence (NICE); 2011 Mar. PMID: 28481492 Free Books & Documents. Review.
-
NICE DSU Technical Support Document 8: An Introduction to the Measurement and Valuation of Health for NICE Submissions [Internet].London: National Institute for Health and Care Excellence (NICE); 2011 Aug. London: National Institute for Health and Care Excellence (NICE); 2011 Aug. PMID: 28481495 Free Books & Documents. Review.
Cited by
-
Fractional Exhaled Nitric Oxide Testing for the Diagnosis and Management of Asthma: a Health Technology Assessment.Ont Health Technol Assess Ser. 2024 Jul 31;24(5):1-225. eCollection 2024. Ont Health Technol Assess Ser. 2024. PMID: 39329005 Free PMC article.
-
Economic evaluation of NALIRIFOX vs. nab-paclitaxel and gemcitabine regimens for first-line treatment of metastatic pancreatic ductal adenocarcinoma from U.S. perspective.Cost Eff Resour Alloc. 2024 Sep 18;22(1):70. doi: 10.1186/s12962-024-00578-5. Cost Eff Resour Alloc. 2024. PMID: 39294689 Free PMC article.
-
Cost-effectiveness of early vs delayed use of abemaciclib combination therapy for patients with high-risk hormone receptor-positive/human epidermal growth factor receptor 2-negative early breast cancer.J Manag Care Spec Pharm. 2024 Sep;30(9):942-953. doi: 10.18553/jmcp.2024.30.9.942. J Manag Care Spec Pharm. 2024. PMID: 39213142 Free PMC article.
-
Modelling Adverse Events in Patients Receiving Chronic Oral Corticosteroids in the UK.Pharmacoecon Open. 2024 Nov;8(6):923-934. doi: 10.1007/s41669-024-00520-8. Epub 2024 Aug 28. Pharmacoecon Open. 2024. PMID: 39196476 Free PMC article.
-
The Health Impact of Waiting for Elective Procedures in the NHS in England: A Modeling Framework Applied to Coronary Artery Bypass Graft and Total Hip Replacement.Med Decis Making. 2024 Jul;44(5):572-585. doi: 10.1177/0272989X241256639. Epub 2024 Jun 10. Med Decis Making. 2024. PMID: 38855915 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
